SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-17-062623
Filing Date
2017-10-18
Accepted
2017-10-18 06:01:34
Documents
16
Period of Report
2017-10-18
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a17-24012_18k.htm 8-K 23004
2 EX-99.1 a17-24012_1ex99d1.htm EX-99.1 20910
3 GRAPHIC g240121moi001.gif GRAPHIC 109930
4 GRAPHIC g240121moi002.gif GRAPHIC 74184
5 GRAPHIC g240121moi003.gif GRAPHIC 117647
6 GRAPHIC g240121moi004.gif GRAPHIC 92582
7 GRAPHIC g240121moi005.gif GRAPHIC 89446
8 GRAPHIC g240121moi006.gif GRAPHIC 81240
9 GRAPHIC g240121moi007.gif GRAPHIC 83108
10 GRAPHIC g240121moi008.gif GRAPHIC 95695
11 GRAPHIC g240121moi009.gif GRAPHIC 84475
12 GRAPHIC g240121moi010.gif GRAPHIC 131743
13 GRAPHIC g240121moi011.gif GRAPHIC 109460
14 GRAPHIC g240121moi012.gif GRAPHIC 105815
15 GRAPHIC g240121moi013.gif GRAPHIC 82699
16 GRAPHIC g240121moi014.gif GRAPHIC 64363
  Complete submission text file 0001104659-17-062623.txt   1868163
Mailing Address 281 TRESSER BOULEVARD, 9TH FLOOR STAMFORD CT 06901
Business Address 281 TRESSER BOULEVARD, 9TH FLOOR STAMFORD CT 06901 203-653-3880
Loxo Oncology, Inc. (Filer) CIK: 0001581720 (see all company filings)

IRS No.: 462996673 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36562 | Film No.: 171141701
SIC: 2834 Pharmaceutical Preparations